title: Flupentixol: relevance of stereoselective therapeutic drug monitoring.
authors.forename: Pierre
authors.initials: P
authors.lastname: Baumann
authors.forename: Hartmut
authors.initials: H
authors.lastname: Kirchherr
authors.forename: Patricia
authors.initials: P
authors.lastname: Berney
authors.forename: Christoph
authors.initials: C
authors.lastname: Hiemke
mesh_terms: D014150:Antipsychotic Agents / Q000008:administration & dosage / Q000737:chemistry / Q000493:pharmacokinetics*; D002986:Clinical Trials as Topic / Q000379:methods; D016903:Drug Monitoring / Q000379:methods; D005475:Flupenthixol / Q000008:administration & dosage / Q000737:chemistry / Q000493:pharmacokinetics*; D006801:Humans; D049268:Positron-Emission Tomography / Q000379:methods*; D013237:Stereoisomerism
chemical_list: D014150:Antipsychotic Agents; D005475:Flupenthixol